引用本文:孙和才, 李淑丽.168例慢性HBV感染者HBV基因型分布调查分析[J].中国临床新医学,2009,2(1):35-36.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1333次   下载 1018 本文二维码信息
码上扫一扫!
分享到: 微信 更多
168例慢性HBV感染者HBV基因型分布调查分析
孙和才, 李淑丽
471000 洛阳, 河南科技大学第二附属医院
摘要:
[摘要] 目的 探讨HBV基因型与乙肝的临床转归关系。方法 应用PCR微板核酸分子杂交ELISA法检测168例慢性HBV感染者的HBV基因型,了解在各临床类型中HBV基因型的分布情况,阐明HBV基因型与HBeAg的关系;HBV基因型与乙肝临床转归的关系;HBV基因型与年龄性别的关系。结果 168例慢性HBV感染者中B基因型有78例占46.43%,C基因型有90例占53.57%。在肝硬化与肝癌病人中C基因型(73.17%)明显多于B基因型(26.83%),统计学分析有明显差异(P<0.05)。90例C基因型病人HBeAg阳性62例,HBeAg阴性28例,两者比较有显著性差别(P<0.05)。在高年龄组病人中以C基因型为主。结论  HBV基因型与乙肝临床转归有密切关系,C基因型是导致HBeAg持续阳性,引起肝硬化、肝癌的主要因素之一。
关键词:  HBV基因型  肝硬化肝癌  主要因素
DOI:
分类号:R 512.6
基金项目:
Survey of HBV genotype distribution in 168 cases of chronic HBV infection
SUN He-cai, LI Shu-li
2nd Affiliated Hospital, Henan University of Science and Technology, Luoyang 471000, China
Abstract:
[Abstract] Objective  To discuss the relationship between HBV genotypes and the clinical outcome of hepatitis B.Methods HBV genotypes were detected by PCR-DNA hybridization-plate-ELISA in 168 cases of chronic HBV infection, to understand HBV genotype distribution of different clinical types, clarify the rclationship between HBeAg and HBV genotype the relationship between HBV genotype and Clinical outcome of the liver; the relationship between HBV genotype and age-sex.Results In 168 cases of chronic HBV infection, there were 78 cases of genotype B (46.43%), 90 cases of C genotype (53.57%). In patients with liver cirrhosis and liver cancer, C genotype (73.17%) was significantly more than genotype B (26.83%), with statistically significantly difference (P<0.05).In 90 cases of C genotype, 62 patients were HBeAg positive and 28 cases HBeAg negative, and there was a significant difference (P<0.05). In the high age group C genotype was dominant.Conclusion HBV genotype and clinical outcome of hepatitis B have the close relation, C genotype is one of primary causes of sustained HBeAg positive, liver, cirrhosis.and liver cancer.
Key words:  HBV genotypes  Liver cirrhosis liver cancer  Main factors